
Ares Commercial Real Estate
Financial Services · USD
Price
$4.78
Cap
$264M
Earnings
2/2 beat
30d Trend
+0%
Upper half of range — momentum is positive
Target range: $5 – $6 (consensus: $5.33)
Consensus: Hold
Earnings history
Q4 2025
BEAT
0.15 vs -0.03
Q1 2025
BEAT
0.13 vs 0.08
Key macro factors
Interest Rate Environment: As a commercial real estate (CRE) lender, ACRE is significantly impacted by interest rates. Rising rates increase borrowing costs for CRE projects, potentially reducing demand for new loans and raising the risk of defaults on existing variable-rate loans. Higher rates also influence property valuations and REIT financing expenses.
Commercial Real Estate Market Health: The overall stability and health of the commercial real estate market are crucial for ACRE's performance. Factors such as property valuations, vacancy rates, and tenant demand directly affect the performance of ACRE's loan portfolio and opportunities for new originations. Global economic slowdowns, as suggested by the IMF's downgraded growth forecasts, could negatively impact CRE demand. [context: IMF Set to Downgrade Global Growth Forecasts Amid Middle East Conflict]
General Economic Growth and Employment: Robust economic growth and low unemployment rates typically support the commercial real estate sector by driving business expansion and demand for commercial properties. While the US economy shows positive job growth, broader threats to global growth and geopolitical instability (e.g., Middle East conflict) could temper investor confidence and indirectly affect the ability of CRE borrowers to service their debts. [context: US Economy Adds 178,000 Jobs in March, Unemployment Dips to 4.3%, Middle East Conflict Drives Oil Prices Higher, Threatens Global Growth]
Ares Commercial Real Estate Corporation is a specialty finance company that originates and invests in commercial real estate loans and related investments in the United States.
QUANT SCORE
Want full analysis on every stock?
Brain47 provides AI-powered research across 72,000+ instruments. Stocks, ETFs, REITs and more.
Join Brain47 — FreeGenerated by Brain47 AI. Educational research only. Not financial advice. Brain47 is not authorised by the FCA to provide investment advice.
